1 El-Hayek G, Bangalore S, Casso Dominguez A, Devireddy C, Jaber W, Kumar G, et al. Meta-analysis of randomized clinical trials comparing biodegradable polymer drug-eluting stent to second-generation durable polymer drug-eluting stents. JACC Cardiovasc Interv. 2017;10(5):462–73.
2 Buccheri S, James S, Lindholm D, Fröbert O, Olivecrona GK, Persson J, et al. Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish Coronary and Angioplasty Registry (SCAAR). Eur Heart J. 2019;40(31):2607–15.
3 Grimfjärd P, Bergman E, Buccheri S, Erlinge D, Lagerqvist B, Svennblad B, et al. Outcome of PCI with Xience versus other commonly used modern drug eluting stents: a SCAAR report. Catheter Cardiovasc Interv. 2021;98(2):E197–204.
4 Taglieri N, Bruno AG, Ghetti G, Marrozzini C, Saia F, Galié N, Palmerini T. Target lesion failure with current drug-eluting stents: evidence from a comprehensive network meta-analysis. JACC Cardiovasc Interv. 2020;13(24):2868–78.
5 Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.
6 Ali ZA, Gao R, Kimura T, Onuma Y, Kereiakes DJ, Ellis SG, et al. Three-year outcomes with the absorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials. Circulation. 2018;137(5):464–79.
7 Mallery JA, Tobis JM, Gessert J, Griffith J, Bessen M, Macleay L, Henry WL. Identification of tissue components in human atheroma by an intravascular ultrasound imaging catheter. Circulation.1988;78(4):II22.
8 Yock PG, Fitzgerald PJ. Intravascular ultrasound: state of the art and future directions. Am J Cardiol. 1998;81(7A):27E–32E.
9. Kuku KO, Singh M, Ozaki Y, Dan K, Chezar-Azerrad C, Waksman R, Garcia-Garcia HM. Near-infrared spectroscopy intravascular ultrasound imaging: state of the art. Front Cardiovasc Med. 2020;7:107.
10 Popescu DP, Choo-Smith LP, Flueraru C, Mao Y, Chang S, Disano J, et al. Optical coherence tomography: fundamental principles, instrumental designs and biomedical applications. Biophys Rev. 2011;3(3):155.
11 Räber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention. 2018;14(6):656–77.
12 Johnson TW, Räber L, Di Mario C, Bourantas CV, Jia H, Mattesini A, et al. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention. 2019;15(5):434–51.
13 Lee SY, Mintz GS, Kim JS, Kim BK, Jang Y, Hong MK. Long-term clinical outcomes of drug-eluting stent malapposition. Korean Circ J. 2020;50(10):880–9.
14 Taniwaki M, Radu MR, Zaugg S, Amabile N, Garcia-Garcia HM, Yamaji K, et al. Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography. Circulation. 2016;133:650–60.
15 Souteyrand G, Amabile N, Mangin L, Chabin X, Meneveau N, Cayla G, et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J. 2016;37(15):1208–16.
16 Prati F, Romagnoli E, Burzotta F, Limbruno U, Gatto L, La Manna A, et al. Clinical impact of OCT findings during PCI: The CLI-OPCI II study. JACC Cardiovasc Imaging. 2015;8(11):1297–305.
17 Kang DY, Ahn JM, Yun SC, Hur SH, Cho YK, Lee CH, et al. Optical coherence tomography-guided or intravascular ultrasound guided percutaneous coronary intervention: the OCTIVUS randomized clinical trial. Circulation. 2023;148(16):1195–206.
18 Stone GW. Intravascular imaging guidance for percutaneous coronary intervention: a «real-time» updated network meta-analysis. Presented at ESC Congress 2023.
19 Lee JM, Choi KH, Song YB, Lee JY, Lee SJ, Lee SY, et al. Intravascular imaging-guided or angiography-guided complex PCI. N Engl J Med. 2023;388(18):1668–79.
20 Holm NR, Andreasen LN, Neghabat O, Laanmets P, Kumsars I, Bennett J, et al. OCT or angiography guidance for PCI in complex bifurcation lesions. N Engl J Med. 2023;389(16):1477–87.
21 Ali ZA, Landmesser U, Maehara A, Matsumura M, Shlofmitz RA, Guagliumi G, et al. Optical coherence tomography-guided versus angiography-guided PCI. N Engl J Med. 2023;389(16):1466–76.
22 Erlinge D, Maehara A, Ben-Yehuda O, Bøtker HE, Maeng M, Kjøller-Hansen L, et al. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. Lancet. 2021;397(10278):985–95.
23 Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–35.
24 Prati F, Romagnoli E, Gatto L, La Manna A, Burzotta F, Ozaki Y, et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J. 2020;41(3):383–91.
25 Diletti R, den Dekker WK, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, et al. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial. Lancet. 2023;401(10383):1172–82.
26 Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med. 2019;381(15):1411–21.
27 Kedhi E, Berta B, Roleder T, Hermanides RS, Fabris E, IJsselmuiden AIJ, et al. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial. Eur Heart J. 2021;42(45):4671–9.
28 Räber L, Ueki Y, Otsuka T, Losdat S, Häner JD, Lonborg J, et al. Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial. JAMA. 2022;327(18):1771–81.
29 Stone GW, Maehara A, Ali ZA, Held C, Matsumura M, Kjøller-Hansen L, et al. Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque. J Am Coll Cardiol. 2020;76(20):2289–301.
Mit der Kommentarfunktion bieten wir Raum für einen offenen und kritischen Fachaustausch. Dieser steht allen SHW Beta Abonnentinnen und Abonnenten offen. Wir publizieren Kommentare solange sie unseren Richtlinien entsprechen.